Juha O Rinne (J O Rinne, Juha Rinne)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Topics

Physical Activity

Randomized Controlled Trial

Positron Emission Tomography

Top Venues

Nature medicine

EJNMMI research

Movement disorders : official journal of the Movement Disorder Society

Annals of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O Rinne, Albert C Ludolph, Ralf Bodenschatz, Holly Kordasiewicz, Eric E Swayze, Bethany Fitzsimmons, Laurence Mignon, Katrina M Moore, Chris Yun, Tiffany Baumann, Dan Li, Daniel A Norris, Rebecca Crean, Danielle L Graham, Ellen Huang, Elena Ratti, C Frank Bennett, Candice Junge, Roger M Lane
Author Correction: Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. Nature medicine (2023)
Henri J Huttunen, Sigrid Booms, Magnus Sjögren, Vera Kerstens, Jarkko Johansson, Rebecka Holmnäs, Jani Koskinen, Natalia Kulesskaya, Patrik Fazio, Max Woolley, Alan Brady, Julia Williams, David Johnson, Narges Dailami, William Gray, Reeta Levo, Mart Saarma, Christer Halldin, Johan Marjamaa, Julio Resendiz-Nieves, Irena Grubor, Göran Lind, Johanna Eerola-Rautio, Tuomas Mertsalmi, Mattias Andréasson, Gesine Paul, Juha O Rinne, Riku Kivisaari, Hjalmar Bjartmarz, Per Almqvist, Andrea Varrone, Filip Scheperjans, Håkan Widner, Per Svenningsson
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 Trial. Movement disorders : official journal of the Movement Disorder Society (2023)
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O Rinne, Albert C Ludolph, Ralf Bodenschatz, Holly Kordasiewicz, Eric E Swayze, Bethany Fitzsimmons, Laurence Mignon, Katrina M Moore, Chris Yun, Tiffany Baumann, Dan Li, Daniel A Norris, Rebecca Crean, Danielle L Graham, Ellen Huang, Elena Ratti, C Frank Bennett, Candice Junge, Roger M Lane
Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. Nature medicine (2023)
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O Rinne, Albert C Ludolph, Ralf Bodenschatz, Holly Kordasiewicz, Eric E Swayze, Bethany Fitzsimmons, Laurence Mignon, Katrina M Moore, Chris Yun, Tiffany Baumann, Dan Li, Daniel A Norris, Rebecca Crean, Danielle L Graham, Ellen Huang, Elena Ratti, C Frank Bennett, Candice Junge, Roger M Lane
Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. Nature medicine (2023)
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O Rinne, Albert C Ludolph, Ralf Bodenschatz, Holly Kordasiewicz, Eric E Swayze, Bethany Fitzsimmons, Laurence Mignon, Katrina M Moore, Chris Yun, Tiffany Baumann, Dan Li, Daniel A Norris, Rebecca Crean, Danielle L Graham, Ellen Huang, Elena Ratti, C Frank Bennett, Candice Junge, Roger M Lane
Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. Nature medicine (2023)
Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O Rinne, Albert C Ludolph, Ralf Bodenschatz, Holly Kordasiewicz, Eric E Swayze, Bethany Fitzsimmons, Laurence Mignon, Katrina M Moore, Chris Yun, Tiffany Baumann, Dan Li, Daniel A Norris, Rebecca Crean, Danielle L Graham, Ellen Huang, Elena Ratti, C Frank Bennett, Candice Junge, Roger M Lane
Tau-targeting antisense oligonucleotide MAPT Rx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. Nature medicine (2023)
Juha O Rinne, Aurelija Jucaite, Zsolt Cselényi, Lars Farde
Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy. Movement disorders : official journal of the Movement Disorder Society 37 (8) (2022)
S K Vainio, Alex M Dickens, Markus Matilainen, Francisco R López-Picón, Richard Aarnio, Olli Eskola, Olof Solin, Daniel Clive Anthony, Juha O Rinne, Laura M Airas, Merja Haaparanta-Solin
Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation. EJNMMI research 12 (1) (2022)
Riikka M Ajalin, Haidar Al-Abdulrasul, Jouni M Tuisku, Jussi E S Hirvonen, Tero Vahlberg, Salla Lahdenpohja, Juha O Rinne, Anna E Brück
Cannabinoid Receptor Type 1 in Parkinson's Disease: A Positron Emission Tomography Study with [ 18 F]FMPEP-d 2 . Movement disorders : official journal of the Movement Disorder Society 37 (8) (2022)
Elina Rauhala, Jarkko Johansson, Mira Karrasch, Olli Eskola, Tuula Tolvanen, Riitta Parkkola, Kirsi A Virtanen, Juha O Rinne
Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study. EJNMMI research 12 (1) (2022)
Teemu Kipinoinen, Sini Toppala, Juha O Rinne, Matti H Viitanen, Antti M Jula, Laura L Ekblad
Association of Midlife Inflammatory Markers With Cognitive Performance at 10-Year Follow-up. Neurology 99 (20) (2022)
Ruth Stephen, Tiia Ngandu, Yawu Liu, Markku Peltonen, Riitta Antikainen, Nina Kemppainen, Tiina Laatikainen, Jyrki M P Lötjönen, Juha O Rinne, Timo E Strandberg, Jaakko Tuomilehto, Ritva Vanninen, Hilkka Soininen, Miia Kivipelto, Alina Solomon, null null
Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis. The journals of gerontology. Series A, Biological sciences and medical sciences 76 (8) (2021)
Sari Aaltonen, Katja Waller, Henri Vähä-Ypyä, Juha O Rinne, Harri Sievänen, Karri Silventoinen, Jaakko A Kaprio, Urho M Kujala
Motives for physical activity in older men and women: A twin study using accelerometer-measured physical activity. Scandinavian journal of medicine & science in sports 30 (8) (2020)
S K Vainio, Alex M Dickens, Jouni Tuisku, Olli Eskola, Olof Solin, Eliisa S Löyttyniemi, Daniel Clive Anthony, Juha O Rinne, Laura M Airas, Merja Haaparanta-Solin
Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation. EJNMMI research 9 (1) (2019)
Urho M Kujala, Pekka Hautasaari, Henri Vähä-Ypyä, Katja Waller, Noora Lindgren, Paula Iso-Markku, Kauko Heikkilä, Juha O Rinne, Jaakko A Kaprio, Harri Sievänen
Chronic diseases and objectively monitored physical activity profile among aged individuals - a cross-sectional twin cohort study. Annals of medicine 51 (1) (2019)
Alar Kaskikallio, Mira Karrasch, Juha O Rinne, Terhi Tuokkola, Riitta Parkkola, Petra Grönholm-Nyman
Domain-specific cognitive effects of white matter pathology in old age, mild cognitive impairment and Alzheimer's disease. Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition 27 (3) (2019)
Ilkka K Martikainen, Nina Kemppainen, Jarkko Johansson, Jarmo Teuho, Semi Helin, Yawu Liu, S Helisalmi, Hilkka Soininen, Riitta Parkkola, Tiia Ngandu, Miia Kivipelto, Juha O Rinne
Brain β-Amyloid and Atrophy in Individuals at Increased Risk of Cognitive Decline. AJNR. American journal of neuroradiology 40 (1) (2018)
Daniel Fellman, Juha Salmi, Liisa Ritakallio, Ulla Ellfolk, Juha O Rinne, Matti Laine
Training working memory updating in Parkinson's disease: A randomised controlled trial. Neuropsychological rehabilitation 30 (4) (2018)